2011
DOI: 10.1681/asn.2010091006
|View full text |Cite
|
Sign up to set email alerts
|

Risks and Benefits of Sweet Pee

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…SGLT1 is expressed in intestinal epithelial cells and SGLT1 as well as SGLT2 in renal epithelial cells thus accomplishing the concentrative cellular uptake of glucose from the intestinal or renal tubular lumen across the apical cell membrane [9,13]. The low luminal glucose concentrations provide some protection against luminal bacterial growth and genetic or pharmacological inhibition of the carriers may favor the development of urinary tract infection [14,15] and diarrhea [16,17]. SGLT1 expression is, however, not restricted to renal and intestinal epithelia [18], but has also been observed in heart [18,19], lung [18], liver [18], tumor cells [20][21][22][23][24][25][26][27] and lymphocytes [28].…”
Section: Introductionmentioning
confidence: 99%
“…SGLT1 is expressed in intestinal epithelial cells and SGLT1 as well as SGLT2 in renal epithelial cells thus accomplishing the concentrative cellular uptake of glucose from the intestinal or renal tubular lumen across the apical cell membrane [9,13]. The low luminal glucose concentrations provide some protection against luminal bacterial growth and genetic or pharmacological inhibition of the carriers may favor the development of urinary tract infection [14,15] and diarrhea [16,17]. SGLT1 expression is, however, not restricted to renal and intestinal epithelia [18], but has also been observed in heart [18,19], lung [18], liver [18], tumor cells [20][21][22][23][24][25][26][27] and lymphocytes [28].…”
Section: Introductionmentioning
confidence: 99%